Stock Taper
SCREENER COMPARE ANY 2 STOCKS
EBS
EMERGENT BIOSOLUTIONS INC.
NYSE
$5.91
▼ DOWN 0.51% (-0.03)

KEY STATISTICS

Market Cap$304.93 M
52w High$14.06
52w Low$4.36
Dividend Yield—
Frequency—
P/E4.10
Volume1.24M
Shares Out.51.60M

COMPANY

LEADERSHIP

Joseph C. Papa Jr.
CHIEF EXECUTIVE
Joseph C. Papa Jr.

COMPENSATION 2026

Salary$1,037,385
Stock Awards$1,638,500
Incentive Plan Pay$1,446,640
All Other Comp.$7,122
Total$5,321,147

ABOUT

SECTOR
Healthcare
WENT PUBLIC
November 15, 2006
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
900

PRICE TARGET

Target High$10.00
Target Low$10.00
Target Median$10.00
Target Consensus$10.00

UPCOMING EARNINGS

DateNov 4, 2026
DayWednesday
Rev. Est.$123.22M
NOV
4
WED

PRICE

$5.91 ▼ DOWN 0.51% (−$0.03)
$5.92$6.00$6.089:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM5.91

About Emergent BioSolutions Inc.

https://www.emergentbiosolutions.com ↗

Emergent BioSolutions Inc. develops and provides vaccines, therapeutics, and response solutions for public health threats like bioweapons, infectious diseases, and emergencies, along with contract manufacturing services.

INDUSTRY

Drug Manufacturers - Specialty & Generic

A PRODUCT EMERGENT BIOSOLUTIONS INC. IS KNOWN FOR

NARCAN® Nasal Spray 4 mg
NARCAN® Nasal Spray 4 mg

NARCAN® Nasal Spray is an OTC emergency treatment that quickly reverses opioid overdoses, vital in combating the opioid crisis, with recent non-prescription availability and new packaging highlighting its public health importance.

COMPETITORS

COMPETITOR
AMPH COMPARE
AMRX COMPARE
TEVA COMPARE

Revenue by Products

IconPRODUCTQ2-2025Q3-2025Q4-2025Q2-2026
Product$130.3M $222M ▲$143.8M ▼$226.8M ▲
Contracts and Grants$10.6M $9.1M ▼$4.9M ▼$7.5M ▲

Revenue by Geography

MapREGIONQ1-2024Q2-2024Q3-2024Q4-2024
Services Segment$18.5M $64.7M ▲$14.3M ▼$7.4M ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
136
LISTED HERE
26
RANKED BY POSITION SIZE
AVUV
0.05% · 2.8M
XBI
0.09% · 1.8M
VTS.AX
0.00% · 1.6M
XSU.TO
0.01% · 1.4M
SCHF
0.13% · 636.9K
FESM
0.05% · 509.6K
VETS
0.15% · 412.6K
DFSV
0.02% · 306.4K
PSC
0.03% · 147.6K
XSPU.L
0.01% · 138.7K
PRFZ
0.02% · 118.4K
BSVO
0.03% · 112.9K
GSSC
0.05% · 88.8K
EES
0.06% · 76.0K
FSCC
0.10% · 71.4K
LABU
0.06% · 66.1K
XHYH
0.32% · 28.0K
RSSL
0.01% · 24.7K
AFSM
0.10% · 22.5K
SILX
0.65% · 16.1K
GERM
0.87% · 11.5K
SQLV
0.14% · 9.4K
JHMD
0.14% · 9.4K
DM
DMRI
0.06% · 3.1K
URTY
0.00% · 2.1K
IQIN
0.11% · 2.0K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
65.20%
HOLDERS
347
TOP 12 OF 347 · RANKED BY POSITION SIZE
Blackrock, Inc.
4.7M sh · $39.53M
Blackrock Inc.
3.8M sh · $26.18M
Oak Hill Advisors LP
3.6M sh · $44.66M
Vanguard Group Inc
3.6M sh · $43.93M
Dimensional Fund Advisors LP
3.1M sh · $25.78M
State Street Corp
2.9M sh · $24.56M
American Century Companies Inc
2.8M sh · $23.22M
Blackrock Fund Advisors
2.7M sh · $87.47M
Aberdeen Asset Management Plc/Uk
1.7M sh · $58.92M
Lsv Asset Management
1.7M sh · $14.21M
Charles Schwab Investment Management Inc
1.6M sh · $20.01M
Palisade Capital Management, LP
1.4M sh · $12.58M

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book4
Overall Score1

TRADES BY CONGRESS

HOUSE TRADES
Steve Cohen
Steve Cohen
Sale (Full)
2024-12-11
 Josh Gottheimer
Josh Gottheimer
Sale (Full)
2021-11-05
 Gilbert Cisneros
Gilbert Cisneros
Purchase
2020-11-24

INSIDER TRADES

★
OFFICER: EVP, CGO
Duatschek Stephanie
— · 44.8K shares
2026-08-05
★
OFFICER: EVP, CGO
Duatschek Stephanie
— · —
2026-08-05
★
OFFICER: EVP, CGO
Duatschek Stephanie
— · 6.8K shares
2026-08-05
★
OFFICER: EVP, CGO
Duatschek Stephanie
— · 7.3K shares
2026-08-05

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
1 GRADES IN THE LAST 12 MONTHS
HC Wainwright & Co. BUY

SECTORS PEERS

PEERPRICE
CMPS$13.73COMPARE
CRVS$14.16COMPARE
OLMA$10.27COMPARE
RIGL$46.48COMPARE
AQST$5.02COMPARE
PRTA$9.33COMPARE
SNDL$1.35COMPARE
ORGO$1.74COMPARE